metaBIX Biotech has reached a significant milestone in its commercial expansion strategy with the establishment of a partnership with Sapience, a prominent company operating in India and several Asian countries within the poultry production sector.

Laura Macció, CEO of metaBIX Biotech, emphasized that this collaboration not only extends their geographical reach but also strengthens their position in the global market, granting access to a poultry sector commanding a 65% market share.

The initial phases of the partnership entail the execution of two pilot projects: one in India, where they have already initiated contact with their first client, and another in Thailand. Moreover, metaBIX Biotech, through its alliance with Sapience, will participate in Poultry India, the largest poultry exhibition on the continent at the end of 2024, presenting an opportunity to engage potential clients within the sector.

Macció outlined the medium-term objectives, which include “establishing a branch in the Asian market, encompassing both poultry and pig sectors. By 2026, they aim to inaugurate a commercial and technological center, aiming to broaden their client base and demonstrate the efficacy of their predictive model in addressing environmental and bacterial threats in poultry production.

Concluding her remarks, Macció revealed that “we are also in the final stages of negotiations with one of the largest animal pharmaceutical companies in the world. These joint efforts anticipate our sales to exceed US$1 million in revenue by 2025, which will mark an important milestone in our financial growth”.